BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2687765)

  • 1. Stage-specific transformation of murine B lineage cells by ras and myc.
    Overell RW; Weisser KE; Hess B; Namen AE; Grabstein KH
    Oncogene; 1989 Dec; 4(12):1425-32. PubMed ID: 2687765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy of IL-7 and v-Ha-ras in the in vitro neoplastic progression of murine pre-B cells.
    Chen SC; Redenius D; Young JC; Schwartz RC
    Oncogene; 1993 Aug; 8(8):2119-25. PubMed ID: 8336938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
    Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
    J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The mouse ovarian surface epithelium cells (MOSE) transformation induced by c-myc/K-ras in].
    Yao DS; Li L; Garson K; Vanderhyden BC
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):881-5. PubMed ID: 17533735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential.
    Symonds G; Hartshorn A; Kennewell A; O'Mara MA; Bruskin A; Bishop JM
    Oncogene; 1989 Mar; 4(3):285-94. PubMed ID: 2649846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus.
    Blasi E; Radzioch D; Merletti L; Varesio L
    Cancer Biochem Biophys; 1989 Oct; 10(4):303-17. PubMed ID: 2695237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.
    Dyall-Smith D; Cory S
    Oncogene Res; 1988 May; 2(4):403-9. PubMed ID: 2840624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroviral v-myc infection of primary fetal liver cells: transformation of monocytes in vitro.
    Birchenall-Roberts MC; Engelmann GL; Keller JR; Lohrey N; Ruscetti FW
    Oncogene; 1989 Jun; 4(6):731-5. PubMed ID: 2786619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation of mixed phenotype cell lines with ras-myc- and raf-myc-containing retroviral vectors after infection of murine long-term bone marrow cultures.
    Spoor E; Ziegler SF; Overell RW; deVries P; Williams DE
    Exp Hematol; 1991 Aug; 19(7):664-8. PubMed ID: 1716589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
    Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
    J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mature murine B lymphocytes immortalized by Kirsten sarcoma virus.
    Lichtman AH; Reynolds DS; Faller DV; Abbas AK
    Nature; 1986 Dec 4-10; 324(6096):489-91. PubMed ID: 3024015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.
    Kohl NE; Ruley HE
    Oncogene; 1987; 2(1):41-8. PubMed ID: 2830582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
    J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceleration of B-lymphoid tumorigenesis in E mu-myc transgenic mice by v-H-ras and v-raf but not v-abl.
    Langdon WY; Harris AW; Cory S
    Oncogene Res; 1989; 4(4):253-8. PubMed ID: 2549487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
    Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
    Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive relaxation of Go-arrest controls and altered responsiveness to insulin, EGF and thrombin in CCL39 lung fibroblasts over-expressing myc and ras oncogenes.
    Pichon F; Seuwen K; Pouysségur J; Lagarde AE
    Oncogene; 1988 Oct; 3(4):373-81. PubMed ID: 3078948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
    Vaux DL; Cory S; Adams JM
    Nature; 1988 Sep; 335(6189):440-2. PubMed ID: 3262202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immortalization of murine B cells in vitro with oncogene-containing retroviral vectors.
    Grabstein KH; Hess B; Weisser KE; Clark L; Goodwin R; Overell RW
    J Immunol; 1992 Sep; 149(5):1524-30. PubMed ID: 1506681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth of E mu-myc transgenic B-lymphoid cells in vitro and their evolution toward autonomy.
    Langdon WY; Harris AW; Cory S
    Oncogene Res; 1988; 3(3):271-9. PubMed ID: 3144697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of oncogenes in normal and transformed murine B lymphocytes.
    DeCino P; Lernhardt W; Herbst H; Raschke WC
    Oncogene Res; 1988; 3(1):33-7. PubMed ID: 3264606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.